Conversely, altered NLRP3 inflammasome activation capacity called NLRP3 inflammasome exhaustion has been described in infectious diseases such as sepsis [6] or severe COVID-19 [7] in association with deleterious outcomes. Here, NLRP3 is linked to COVID-19.